Golden
Abbott Laboratories

Abbott Laboratories

American global pharmaceuticals and health care products company.

Abbott Laboratories fell just short of Wall Street estimates for quarterly revenue on Wednesday, as weakness in the medical device maker's cardiovascular business overshadowed strong performance in its fast-growing diabetes care unit.
Abbott Laboratories Inc reported a 70.5% jump in quarterly profit on Wednesday, powered by demand for its blood sugar monitors and cardiovascular devices. The company's net earnings rose to $960 million, or 53 cents per share, in the third quarter ended Sept. 30, from $563 million, or 32 cents...
This study outcome should be a crucial step forward for Abbott Laboratories (ABT) in its endeavor to boost TBI diagnosis and treatment.
NEW YORK, December 10, 2018 /PRNewswire/ -- Cardiac marker analyzers to witness promising revenue growth. CLIA analyzers to account for maximum revenue share...

No more news to show.